Charpentier G - Search Results

1

Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes: a nationwide French survey.

Charpentier G, Genès N, Vaur L, Amar J, Clerson P, Cambou JP, Guéret P; ESPOIR Diabetes Study Investigators. Charpentier G, et al. Diabetes Metab. 2003 Apr;29(2 Pt 1):152-8. doi: 10.1016/s1262-3636(07)70022-8. Diabetes Metab. 2003. PMID: 12746636

2

Cooperation between general practitioners and diabetologists and clinical audit improve the management of type 2 diabetic patients.

Varroud-Vial M, Mechaly P, Joannidis S, Chapiro O, Pichard S, Lebigot A, Moulonguet M, Attali C, Bayle A, Bénier J, Charpentier G. Varroud-Vial M, et al. Among authors: charpentier g. Diabetes Metab. 1999 Mar;25(1):55-63. Diabetes Metab. 1999. PMID: 10335424

3

Management of drugs affecting blood glucose in diabetic patients with renal failure.

Charpentier G, Riveline JP, Varroud-Vial M. Charpentier G, et al. Diabetes Metab. 2000 Jul;26 Suppl 4:73-85. Diabetes Metab. 2000. PMID: 10922977 Review.

4

Mutation screening of the PPARalpha gene in type 2 diabetes associated with coronary heart disease.

Lacquemant C, Lepretre F, Pineda Torra I, Manraj M, Charpentier G, Ruiz J, Staels B, Froguel P. Lacquemant C, et al. Among authors: charpentier g. Diabetes Metab. 2000 Nov;26(5):393-401. Diabetes Metab. 2000. PMID: 11119019

5

[Silent ischemic cardiopathy: which diabetics to examine?].

Charpentier G, Riveline JP, Lardoux H, Mathieu E, Requeda E, Varroud-Vial M. Charpentier G, et al. Arch Mal Coeur Vaiss. 2000 Dec;93 Spec No 4:25-32. Arch Mal Coeur Vaiss. 2000. PMID: 11296459 Review. French.

6

Improved glycaemic control by addition of glimepiride to metformin monotherapy in type 2 diabetic patients.

Charpentier G, Fleury F, Kabir M, Vaur L, Halimi S. Charpentier G, et al. Diabet Med. 2001 Oct;18(10):828-34. doi: 10.1046/j.1464-5491.2001.00582.x. Diabet Med. 2001. PMID: 11678974 Clinical Trial.

7

Predictors of response to glimepiride in patients with type 2 diabetes mellitus.

Charpentier G, Vaur L, Halimi S, Fleury F, Derobert E, Grimaldi A, Oriol V, Etienne S, Altman JJ; DIAMETRE. Charpentier G, et al. Diabetes Metab. 2001 Nov;27(5 Pt 1):563-71. Diabetes Metab. 2001. PMID: 11694855 Clinical Trial.

8

Effects of clinical audit on the quality of care in patients with type 2 diabetes: results of the DIABEST pilot study.

Varroud-Vial M, Charpentier G, Vaur L, Attali JR, Balarac N, Cervantes P, Kleinebreil L, Levy-Marchal C, Preiss P, Weisselberg C, Eschwege E. Varroud-Vial M, et al. Among authors: charpentier g. Diabetes Metab. 2001 Dec;27(6):666-74. Diabetes Metab. 2001. PMID: 11852375

9

Effect on compliance, acceptability of blood glucose self-monitoring and HbA(1c) of a self-monitoring system developed according to patient's wishes. The ACCORD study.

Halimi S, Charpentier G, Grimaldi A, Grenier JL, Baut F, Germain B, Magnette J. Halimi S, et al. Among authors: charpentier g. Diabetes Metab. 2001 Dec;27(6):681-7. Diabetes Metab. 2001. PMID: 11852377 Clinical Trial.

10

Oral combination therapy for type 2 diabetes.

Charpentier G. Charpentier G. Diabetes Metab Res Rev. 2002 Sep-Oct;18 Suppl 3:S70-6. doi: 10.1002/dmrr.278. Diabetes Metab Res Rev. 2002. PMID: 12324989 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

284 results

Search Page

Filters